A detailed history of Principal Securities, Inc. transactions in Novo Nordisk A S stock. As of the latest transaction made, Principal Securities, Inc. holds 41,787 shares of NVO stock, worth $4.37 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares
41,787
Previous 41,079 1.72%
Holding current value
$4.37 Million
Previous $5.86 Billion 15.14%
% of portfolio
0.12%
Previous 0.16%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

BUY
$119.07 - $145.42 $84,301 - $102,957
708 Added 1.72%
41,787 $4.98 Billion
Q2 2024

Jul 31, 2024

BUY
$122.71 - $146.91 $845,471 - $1.01 Million
6,890 Added 20.15%
41,079 $5.86 Billion
Q1 2024

May 10, 2024

BUY
$102.11 - $135.92 $721,815 - $960,818
7,069 Added 26.07%
34,189 $4.39 Billion
Q4 2023

Feb 07, 2024

BUY
$87.78 - $105.45 $2.38 Million - $2.86 Million
27,120 New
27,120 $2.81 Billion

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $236B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Principal Securities, Inc. Portfolio

Follow Principal Securities, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Principal Securities, Inc. with notifications on news.